2108 Emergen20Logo 24

The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures. Rising focus by major companies on product/service expansion into new and untapped domestic markets, increasing investments in strategic agreements, favourable government policies and regulations, and growing competition in the market are some major trends observed in the Cell-Free DNA (cfDNA) Testing market. Development of more advanced offerings is driving rising demand and deployment in respective sectors/industries, and this is expected to drive Cell-Free DNA (cfDNA) Testing market revenue growth to a significant extent over the forecast period.

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Cell-Free DNA (cfDNA) Testing Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2020 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Download FREE Sample Brochure (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/156

Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period. However, The expensive equipment and lack of skilled healthcare professionals are expected to restrain the market growth in the forecast timeframe. Global Cell-Free DNA (cfDNA) Testing market forecast has been provided following thorough study, focus, comparison, and analysis of a varying range of factors and past market forecast and present outcomes. Cell-Free DNA (cfDNA) Testing Market forecast is made possible through, but has not been limited to, a study and analysis of a variety of factors and trends, and these are verified through interviews with industry experts and companies operating in the market.  The report provides Cell-Free DNA (cfDNA) Testing market forecast, supported by detailed insights historical data and revenues, past and current market trends, industry trends, consumer trends, market size, market share, market growth, along with ranging impacts of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2020–2028. The report includes profiles of major players in the market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Top key vendors in Cell-Free DNA (cfDNA) Testing Market include are:

Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others.

Key Highlights From The Report

  • In August 2019, Agilent Technologies Inc. announced the acquisition of a leading manufacturer of innovative healthcare equipment, BioTek Instruments, Inc. This acquisition will expand Agilent’s product portfolio and its presence in North America.
  • Cell-free fetal DNA is a non-invasive procedure and therefore does not pose a health risk of CVS (chorionic villus sampling) or amniocentesis, like pain and any slight chance of infection. Due to these benefits, the cell-free fetal DNA segment held the largest market share of 48.8% in the Cell-Free DNA (cfDNA) testing market, in 2019.
  • The MPSS technology segment is anticipated to dominate the global market with a CAGR of 26.7%, owing to the advantage of producing a measurable profile of gene expression in cells or tissues.
  • The gynecology segment is anticipated to lead the market during the forecasted period, as the cell-free DNA approach is being used to detect genetic issues of baby and to diagnose pregnancy complications such as pregnancy loss.
  • North America is accounted for the largest market with a share of 33.6% in 2019, owing to the increasing chronic diseases and pregnancy problems in this region due to the changes in lifestyles of the population. Besides, the adoption of advanced technology in hospitals is also expected to boost the market shortly.

Request customized copy of Cell-Free DNA (cfDNA) Testing [email protected] https://www.emergenresearch.com/request-for-customization/156

Emergen Research has segmented the global Cell-Free DNA (cfDNA) Testing Market on the basis of type, technology, application, and region:

  • Type Outlook (Revenue, USD Billion; 2017-2027)
    • Cell-free fetal DNA (NIPT)
    • Circulating tumor DNA
    • Donor-derived cell-free DNA
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • MPSS
    • t-MPS
    • SNP
    • Others
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Transplantation
    • Gynecology
    • Oncology

 

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Proceed To Buy: https://www.emergenresearch.com/select-license/156

Table of Content

Chapter 1. Methodology & Sources

    1.1. Cell-Free DNA (cfDNA) Testing Market Definition

    1.2. Research Scope 

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Cell-Free DNA (cfDNA) Testing Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2021-2028

Chapter 3. Key Insights

Chapter 4. Cell-Free DNA (cfDNA) Testing Market Segmentation & Impact Analysis

    4.1. Cell-Free DNA (cfDNA) Testing Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Cell-Free DNA (cfDNA) Testing Market indicators analysis

          4.2.2. Cell-Free DNA (cfDNA) Testing Market drivers analysis

                    4.2.2.1. Rapid urbanization and industrialization

                    4.2.2.2. Stringent government regulations regarding carbon emissions

                    4.2.2.3. Increasing prevalence of respiratory diseases

                    4.2.2.4. Rising need to enhance indoor air quality

          4.2.3. Cell-Free DNA (cfDNA) Testing Market restraints analysis

                    4.2.3.1. High cost associated with the maintenance of Cell-Free DNA (cfDNA) Testing products

                    4.2.3.2. Availability of renewable sources of energy

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

 

Continued….

The research provides answers to the following key questions:

  • What will be the growth rate and the market size of the Cell-Free DNA (cfDNA) Testing industry for the forecast period 2020-2027?
  • What are the major driving forces expected to impact the development of the Cell-Free DNA (cfDNA) Testing market across different regions?
  • Who are the major driving forces expected to decide the fate of the Cell-Free DNA (cfDNA) Testing industry worldwide?
  • What are the key barriers and threats believed to hinder the development of the industry?
  • What are the future opportunities in the Cell-Free DNA (cfDNA) Testing market?

Why Choose Emergen Research?

  1. Strong Industry Focus
  2. Extensive Product Offerings
  3. Customer Research Services
  4. Robust Research Methodology
  5. Comprehensive Reports
  6. Latest Technological Developments

To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/cell-free-dna-market

Thank you for reading the report. The report can be customized as per the requirements of the clients. For further information or query about customization, please reach out to us, and we will offer you the report best suited for your needs.

Explore More Related Articles from Emergen Research

3D Printing Healthcare Market

Medical Radiation Detection, Monitoring, and Safety Market

Prenatal Testing Market

Medical Devices Testing Services Market

Cardiac Monitoring & Cardiac Rhythm Management Devices Market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Tags: Cell-Free DNA (cfDNA) Testing Market Growth, Cell-Free DNA (cfDNA) Testing Market Size, Cell-Free DNA (cfDNA) Testing Market

See Campaign: https://www.emergenresearch.com/industry-report/cell-free-dna-market
Contact Information:
Contact Us: Eric Lee Corporate Sales Specialist Emergen Research | Web: www.emergenresearch.com Direct Line: +1 (604) 757-9756 E-mail: [email protected] Facebook | LinkdIn | Twitter | Blogs

Tags:
PR-Wirein, Reportedtimes, Menafn, iCN Internal Distribution, Research Newswire, English